Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2014
10/01/2014EP2782926A1 Peptide sequence design and use thereof for peptide-mediated sirna delivery
10/01/2014EP2782598A2 Recombinant proteins and their therapeutic uses
10/01/2014EP2782597A1 Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
09/2014
09/30/2014USRE45170 Streptococcus suis vaccines and diagnostic tests
09/30/2014US8847026 Soybean variety A1026436
09/30/2014US8847025 Soybean variety A1026642
09/30/2014US8847024 Soybean variety S100305
09/30/2014US8847023 Soybean variety A1026210
09/30/2014US8847014 Nucleotide sequences mediating male fertility and method of using same
09/30/2014US8847012 Genes that increase plant oil and method for using the same
09/30/2014US8847005 Genetically modified major histocompatibility complex mice
09/30/2014US8846952 Detection or quantification of desirable target molecules, novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes
09/30/2014US8846893 Non-ionically bound constructs, and compositions and kits comprising domains
09/30/2014US8846891 Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1)
09/30/2014US8846890 Microbial nanowires
09/30/2014US8846889 Peptide biosynthesis and pain therapy
09/30/2014US8846888 Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same
09/30/2014US8846878 Method and device for isolating a protein sample
09/30/2014US8846874 IgG Fc fragment for a drug carrier and method for the preparation thereof
09/30/2014US8846872 Monoclonal antibodies and diagnostic uses thereof
09/30/2014US8846871 Anti-Notch1 NRR antibodies
09/30/2014US8846866 Aldehyde tags, uses thereof in site-specific protein modification
09/30/2014US8846865 Endolysin OBPgpLYS
09/30/2014US8846860 Methods of decorating hydroxyapatite biomaterials with modular biologically active molecules
09/30/2014US8846842 Production and use of highly functional, highly branched or hyperbranched polylysines
09/30/2014US8846771 Compositions and methods of delivery of pharmacological agents
09/30/2014US8846625 Glucagon-like peptide-2 analogs
09/30/2014US8846624 Modified protein polymers
09/30/2014US8846621 Compositions and methods for treating diseases associated with angiogenesis and inflammation
09/30/2014US8846620 Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
09/30/2014US8846619 Artificial oxygen transport protein
09/30/2014US8846618 Stable formulation of modified GLP-1
09/30/2014US8846617 Inflammation inhibiting compounds
09/30/2014US8846615 MNTF peptides
09/30/2014US8846614 Process for the synthesis of 37-mer peptide pramlintide
09/30/2014US8846611 Skin conditions using human growth hormone
09/30/2014US8846608 Human lactoferrin derived peptides and their use
09/30/2014US8846601 Melanocortin receptor-specific peptides
09/30/2014US8846578 Zinc finger nuclease for the CFTR gene and methods of use thereof
09/30/2014US8846401 Promoters exhibiting endothelial cell specificity and methods of using same
09/30/2014US8846398 Method for preparing human neoplastically transformed cells
09/30/2014US8846391 Methods and compositions for detecting herpes simplex virus type 2
09/30/2014US8846389 AAV4 vector and uses thereof
09/30/2014US8846388 Infectious clones of torque teno virus
09/30/2014US8846386 sVEGFR-2 and its role in lymphangiogenesis modulation
09/30/2014US8846385 Method and means for producing high titer, safe recombinant lentivirus vectors
09/30/2014US8846366 R-hydroxynitrile lyase (R-HNL) random variants and their use for preparing optically pure, sterically hindered cyanohydrins
09/30/2014US8846365 Nucleic acids encoding phosphate fluorescent indicators and methods of using the same
09/30/2014US8846362 Variant LOVD polypeptides and their uses
09/30/2014US8846359 Method of regenerating an enzymatic catalyst
09/30/2014US8846352 Genetically engineered microorganisms that metabolize xylose
09/30/2014US8846345 Recombinant cell line
09/30/2014US8846344 Process for the purification of glycoproteins
09/30/2014US8846342 Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells
09/30/2014US8846341 Marker panels for idiopathic pulmonary fibrosis diagnosis and evaluation
09/30/2014US8846340 Carbohydrate-binding modules of a new family
09/30/2014US8846327 Method of quantifying autoinducer-2
09/30/2014US8846326 Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides
09/30/2014US8846080 Vaccine
09/30/2014US8846058 Shiga toxoid chimeric proteins
09/30/2014US8846056 Anti-RSV immunogens and methods of immunization
09/30/2014US8846055 Virulence determinant within the E2 structural glycoprotein of classical swine fever virus
09/30/2014US8846052 Bacterial toxin vaccine
09/30/2014US8846051 Modulation of replicative fitness by deoptimization of synonymous codons
09/30/2014US8846050 N-domain of carcinoembryonic antigen and compositions, methods and uses thereof
09/30/2014US8846047 Monoclonal antibodies against HMGB1
09/30/2014US8846043 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
09/30/2014US8846042 Multi-specific FAB fusion proteins and methods of use
09/30/2014US8846034 Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
09/30/2014US8846031 Simian adenovirus 41 and uses thereof
09/30/2014US8846025 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
09/30/2014US8846005 APCDD1 inhibitors for treating, diagnosing or detecting cancer
09/30/2014US8846003 Collagen-binding synthetic peptidoglycans, preparation, and methods of use
09/30/2014US8846002 Anti-CD74 immunoconjugates and methods of use
09/30/2014CA2611127C Mutant strains of lactic acid bacteria having a non-phosporylable lactose permease
09/30/2014CA2565306C Plant galactinol synthase homologs
09/30/2014CA2554419C Altering root structure during plant development
09/30/2014CA2506737C Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll)
09/30/2014CA2482597C Compositions and methods for regulation of plant gamma-tocopherol methyltransferase
09/30/2014CA2356706C Novel exendin agonist formulations and methods of administration thereof
09/30/2014CA2281862C Method of hybrid seed production using conditional female sterility
09/30/2014CA2252439C Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
09/25/2014WO2014153270A1 Treatment of cancer using humanized anti-cd19 chimeric antigen receptor
09/25/2014WO2014153111A2 Interleukin-2 muteins for the expansion of t-regulatory cells
09/25/2014WO2014152955A1 Apelin fusion proteins and uses thereof
09/25/2014WO2014152678A1 Compositions and methods for delivering agents to the central nervous system
09/25/2014WO2014152540A1 Compositions and methods of altering cholesterol levels
09/25/2014WO2014152530A1 Variant factor viii polypeptides and methods of their production and use
09/25/2014WO2014152511A1 Methods for promoting wound healing and hair growth
09/25/2014WO2014152447A2 Cloning and use of the ms9 gene from maize
09/25/2014WO2014152231A1 Methods and compositions for bacteriophage therapy
09/25/2014WO2014152195A1 Il-33 antagonists and uses thereof
09/25/2014WO2014152089A1 Compositions and treatments of metabolic disorders using fgf binding protein 3
09/25/2014WO2014152012A2 Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
09/25/2014WO2014151960A2 Methods for controlling t cell proliferation
09/25/2014WO2014151747A1 Methods and compositions with immune therapy for treatment of dementia
09/25/2014WO2014151736A1 Activation of bioluminescence by structural complementation
09/25/2014WO2014151535A1 Gla domains as targeting agents
09/25/2014WO2014151255A1 Methods and compositions for weed control
09/25/2014WO2014151230A2 Method of treating granulomatosis with polyangiitis
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 2916